Publication | Closed Access

Polymer-doxycycline conjugates as fibril disrupters: An approach towards the treatment of a rare amyloidotic disease

Medicinal ChemistryAlzheimer's DiseaseBiochemistryMedicineNatural SciencesPolymer-doxycycline ConjugatesProtein MisfoldingRare Amyloidotic DiseasePharmacologyDrug DiscoveryFibril Disrupters